|1|Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155. (23803726)
Litvinov I.V.... Sasseville D.
|2|Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma. (23600840)
Hanafusa T.... Katayama I.
|3|Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides. (23557425)
Pileri A.... Pimpinelli N.
|4|Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis. (22404649)
Miyagaki T.... Sato S.
|5|Central Nervous System Involvement in Cutaneous T-Cell Lymphoma: 2 Illustrative Cases and a Review of Current Literature. (24262331)
Zhao G.... Shinohara M.M.
|6|The presenting manifestations of subcutaneous panniculitis-like T-cell lymphoma and T-cell lymphoma and cutaneous I^I' T-cell lymphoma may mimic those of rheumatic diseases: a report of 11 cases. (23588884)
Yi L.... Fengchun Z.
|7|Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. (23786842)
Quaglino P.... Bernengo M.G.
|8|Aprepitant in the Treatment of Refractory Pruritus Secondary to Cutaneous T-Cell Lymphoma. (24139470)
Borja-Consigliere H.A.... Tuneu-Valls A.
|9|Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland. (22678563)
VAokevAo L.... Hahtola S.
|10|Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells. (21949767)
Marzec M.... Wasik M.A.
|11|Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/SAczary syndrome cutaneous T-cell lymphoma. (21550694)
Blom A.... Laroche L.
|12|Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma. (21377838)
Schlapbach C.... Hunger R.E.
|13|Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway. (21346774)
Krejsgaard T.... Odum N.
|14|Cutaneous involvement by colonic extranodal NK/T-cell lymphoma mimicking mycosis fungoides: a case report*. (21883363)
Sitthinamsuwan P.... Sukpanichnant S.
|15|Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma. (21649541)
Querfeld C.... Rosen S.T.
|16|Cutaneous T-cell lymphoma (mycosis fungoides) relapsed with different immunological phenotype after bone marrow transplant. (19903173)
Okada S.... Kurokawa M.
|17|T-cell receptor gamma gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis. (19906072)
Goeldel A.L.... Grange F.
|18|The use of synchrotron infrared microspectroscopy in the assessment of cutaneous T-cell lymphoma vs. pityriasis lichenoides chronica. (20415741)
El Bedewi A.... Miller L.M.
|19|Extracorporeal methoxsalen: new drug. Cutaneous T cell lymphoma: for rare patients, but better assessment needed. (19388212) |2009|
|20|Total scalp radiation using image-guided IMRT for progressive cutaneous T cell lymphoma. (19451312)
Samant R.S.... Allan D.S.
|21|Canine epitheliotropic cutaneous T-cell lymphoma: an investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality. (20178496)
Moore P.F.... Hirt B.
|22|Pharmacogenetic contribution of leptin gene polymorphism in cutaneous T-cell lymphoma. (19079651)
Vasku V.... Vasku J.B.
|23|Cutaneous involvement in the lymphoepithelioid variant of peripheral T-cell lymphoma, unspecified (Lennert lymphoma). Report of a case and review of the literature. (19775391)
Summers T.A.... Lupton G.
|24|Strategies for treating cutaneous T-cell lymphoma: part 1: remission. (20729945)
Latkowski J.A.... Heald P.
|25|Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma. (19770436)
Gardner J.M.... Rook A.H.
|26|Denileukin diftitox for the treatment of cutaneous T-cell lymphoma. (19707452)
Kaminetzky D.... Hymes K.B.
|27|Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides. (18245523)
Chong B.F.... Wong H.K.
|28|Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma. (18628465)
Ellis L.... Prince H.M.
|29|Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphoma. (17239936)
Witkiewicz A.... Wasik M.A.
|30|Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat. (19707308)
Duvic M.... Vu J.
|31|ECP versus PUVA for the treatment of cutaneous T-cell lymphoma. (17609808)
|32|Folliculotropic SAczary syndrome: a new variant of cutaneous T-cell lymphoma. (17286634)
Gerami P.... Guitart J.
|33|Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL). (16516674)
|34|Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas. (15816832)
Ni X.... Duvic M.
|35|Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas. (15531468)
Gallardo F.... Servitje O.
|36|The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy. (15578918)
Berger C.L.... Edelson R.
|37|Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL). (15507390)
Vasku J.A.... Vasku V.
|38|Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches. (15202526)
|39|Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. (12006543)
Zhang C.... Duvic M.
|40|Follicular mucinosis associated with early stage cutaneous T-cell lymphoma: successful treatment with interferon alpha-2b and acitretin. (12243671)
Kontochristopoulos G.J.... Zakopoulou N.
|41|Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. (11298531)
Child F.J.... Whittaker S.J.
|42|Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. (11564163)
Qin J.Z.... DAPbbeling U.
|43|Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma. (11594570)
|44|IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression. (10949545)
Asadullah K.... Sterry W.
|45|Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas. (9176388)
Bakels V.... Willemze R.
|46|CD44 variant expression in cutaneous T-cell lymphoma. (9243361)
Orteu C.H.... Whittaker S.J.
|47|p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas. (9331891)
van Haselen C.W.... Willemze R.
|48|Malignant and normal T cells show random use of T-cell receptor alpha chain variable regions in patients with cutaneous T-cell lymphoma. (7615977)
Longley J.... Tigelaar R.
|49|Concurrent eosinophilic fasciitis and cutaneous T-cell lymphoma. Eosinophilic fasciitis as a paraneoplastic syndrome of T-cell malignant neoplasms? (2036034)
Chan L.S.... Cooper K.D.
|50|Lymphomatoid papulosis, cutaneous T-cell lymphoma, and Hodgkin's disease: diseases of activated helper T cells? (2879806)